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Abstract
The aim of this study was to demonstrate the potential of a wireless pixelated β+-sensitive intracerebral probe (PIXSIC) for in vivo
positron emission tomographic (PET) radiopharmacology in awake and freely moving rodents. The binding of [11C]raclopride to D2
dopamine receptors was measured in anesthetized and awake rats following injection of the radiotracer. Competitive binding was
assessed with a cold raclopride injection 20 minutes later. The device can accurately monitor binding of PET ligands in freely moving
rodents with a high spatiotemporal resolution. Reproducible time-activity curves were obtained for pixels throughout the striatum and
cerebellum. A significantly lower [11C]raclopride tracer–specific binding was observed in awake animals. These first results pave the
way for PET tracer pharmacokinetics measurements in freely moving rodents.
I N HUMANS, neuronal activation patterns correlated tobehavior are recorded easily using positron emission
tomography (PET) or functional magnetic resonance imaging.
In animals, the combination of PET tracer pharmacokinetics
measurements with behavioral studies would constitute a
breakthrough for the understanding of functional processes in
the brain.1 However, PET requires anesthesia or severe animal
restraints, which prevent simultaneous behavioral activities.
For the past 10 years, several instruments dedicated to beha-
vioral neuroimaging have been proposed.2 In the simplest
approach, behavioral experiments are carried out after injec-
tion of the tracer, the animals being left free in an open ﬁeld.3
After 30 minutes, animals are anesthetized and brain images
are acquired with microPET. Although attractive, this method
obviously restricts the combination of PET and behavioral
studies to speciﬁc protocols and prevents simultaneous
recordings. Another approach, the RatCAP, relies on a wear-
able PET device allowing for imaging the entire brain.4 In a
third approach, a motion tracking system is used within a PET
scanner.5 Nevertheless, it still requires constraining the animal
in a speciﬁc holder.5 In all approaches, either the bulkiness of
the system or the global constraints strongly limit animal
motion.4
We propose a strategy for in vivo recording of PET tracer
time-activity curves (TACs) in freely moving rats using a
radiosensitive pixelated intracerebral probe and its backpack
supporting the microdriver and the radiofrequency transmit-
ter: PIXSIC. We have previously shown its ability to measure
TACs in anesthetized rats.6 Here we demonstrate that the
probe can provide kinetics measurements of [11C]raclopride, a
well-known dopaminergic D2 receptor tracer, in freely moving
rats using chronically implanted wireless probes.
Materials and Methods
PIXSIC Design
PIXSIC relies on a silicon probe 200 mm thick, 690 mm wide.
and 17mm long hosting 10 pixels of 200 500 mm implanted
in the brain region of interest (Figure 1). The pixel sensor is
based on a reverse-biased, high-resistivity silicon diode.
PIXSIC enables high-sensitivity time-resolved measurements
in a volume deﬁned by the range of beta particles within living
tissues.7,8 The pixelated detection scheme adds “imaging”
features by recording several TACs along the probe position.
The probe design is light, compact, energetically autono-
mous, and based on a wireless radiofrequency data exchange
that empowers free behavioral activity during acquisition.6
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Autoradiography
Probe implantations in high-density D2 regions were opti-
mized with autoradiography. Animals were anesthetized
(single intraperitoneal injection of urethane 1.7 g/kg). The tail
vein was catheterized for radiotracer injection. Twenty min-
utes after injection of 74 MBq of [11C]raclopride, the rat was
sacriﬁced; its brain was removed and frozen in isopentane at
30C. Coronal sections of 20 mm were obtained with a
cryostat at20 C, thaw-mounted on glass microscope slides,
and juxtaposed to a phosphor imager for 60 minutes. After
development, optical densities were measured for the cortex,
the striatum, and the cerebellum using MultiGauge software
(Fujiﬁlm, Tokyo, Japan).
Animal Procedure
Adult male Sprague Dawley rats (350–400 g) were housed
under standard conditions of temperature and humidity and
under artificial light from 8 am to 8 pm. All experiments were
conducted in accordance with European guidelines for the care
of laboratory animals (2010/63/EU), and all experiments were
approved by the animal use ethics committee of the University
of Lyon.
Surgery
All animals (n = 6) were anesthetized with isoﬂurane (ind-
uction 3.5% in air and maintenance 2% in air) after a
subcutaneous injection of buprenorphine for analgesia
(30 ng/kg of rat; Buprecare, Axience SAS, Pantin, France).
Chronic intravenous silicone catheters were surgically
implanted into the right jugular vein situated dorsally
between the scapulae (Vascular Access Button, Instech
Solomon, Plymouth Meeting, PA). Next, as described else-
where,6,9 two probes were stereotaxically implanted for each
animal, in the striatum (a region highly expressing D2
receptors; anteroposterior +0.6, lateral +3.0 from bregma,
and dorsoventral 7.0 below dura) and the cerebellum (a
reference region containing negligible densities in D2
receptors; anteroposterior12.0, lateral0.5 from bregma,
and dorsoventral 6.0 below dura). Both probes were
cemented on the skull (Heraeus, Hanau, Germany). Rats
were left in their cages to recover from surgery for at least
6 days before experimentation.
[11C]Raclopride Synthesis
[11C]Raclopride was synthesized (radiochemical yield of
25% decay corrected) in an automated synthesizer (CER-
MEP Biomedical Cyclotron, Lyon, France). Chemical and
radiochemical purity were determined by high-performance
liquid chromatography (> 98%). Speciﬁc activity of the
injected radiotracer ranged from 50 to 285 GBq/mmol
(1.35 to 7.70 Ci/mmol), and the corresponding injected
raclopride mass ranged from 0.65 to 3.7 nmol/kg.
Figure 1. PIXSIC system. The head socket (A) bears the silicon probe, whose sensitive part is implanted into the brain. This probe is wire bonded to
an application-specific integrated circuit (ASIC) that is protected by a hull. The backpack is carried by the rat and includes radio transmission
components and a power supply that enables the autonomous and wireless operation of the system (B), a connection cable with the head socket (C),
and a harness (D). The animal is equipped with a jugular catheter for radiotracer injections (E).
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PIXSIC Scanning Procedure
Over 45 seconds, 74 MBq (2 mCi) of [11C]raclopride in
0.5 mL saline was injected into the dorsal vein. The TACs
were recorded for 60 minutes. The following three protocols
were applied:
 Protocol 1 (anesthetized rat recordings): three rats were
anesthetized with isoﬂurane. Then PIXSIC was set in
place (probes and electronics backpack) prior to the
[11C]raclopride injection.
 Protocol 2 (awake rat recordings): three rats were
equipped with PIXSIC without any anesthesia. Then each
rat was placed in a box (30  30  35 cm), allowing for
free movement. [11C]Raclopride was injected after 20
minutes’ habituation.
 Protocol 3 (displacement): protocol 2 + 30 minutes after
the injection of [11C]raclopride, unlabeled raclopride was
injected (2 mg/kg in 1 mL/kg saline) in the vein catheter.
Data Analysis
PIXSIC data were averaged every minute. The corresponding
TACs were normalized for radioactive decay, and the
detection sensitivity of each pixel was measured as described
elsewhere.6 The speciﬁc binding ratio (B/F) was calculated as
described elsewhere10 with the following equation:
B=F ¼
Z 60
30
BðtÞdt=
Z 60
30
FðtÞdt:
B represents the specific binding signal, defined as the
difference between total regional radioactivity of the striatum
and that of the cerebellum. The cerebellum was used as a
reference tissue to evaluate free radioligand concentration
and nonspecific binding in the brain (F). This equation
integrates the time curves for B (B(t)) and F (F(t)) from 30 to
50 minutes to make it possible to compare the values
obtained in awake and anesthetized animals. Statistical ana-
lyses were conducted for repeated measurements by com-
paring the means obtained from the awake and anesthetized
animals for each time point by a two-way analysis of variance
(ANOVA), followed by post hoc Bonferonni tests. A p value
less than .05 was considered signiﬁcant.
Results
The aim of the study was to demonstrate the ability of
PIXSIC to record [11C]raclopride TACs in freely moving rats
and to compare results obtained in awake and anesthetized
rats. Figure 2 details the location of the two probes in the
brain by superimposing schematic pixelated probes with
two [11C]raclopride autoradiograms at the striatal and the
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Figure 2. Localization of one
PIXSIC probe in the rat cerebellum
(left) and the second probe in
the cortex (Cx) and striatum (Str)
region (right) in [11C]raclopride
autoradiography (A). Silicon probe
sizes were 200 mm thick, 690 mm
wide, and 17 mm long. The radio-
sensitive pixels (200 mm 500 mm)
are numbered from P01 to P10
(P01–P06 are located in the stria-
tum and P07–P10 are located in
the cortex). Corresponding time-
activity curves (B) after bolus
administration of [11C]raclopride
(74 MBq; 2 mCi; IV, n = 1 rat).
ID = injected dose.
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cerebellar levels. Probe positions were determined using
surgical stereotaxic coordinates conﬁrmed by histologic
controls. Figure 3 shows the corresponding TACs recorded
along the probe in awake and anesthetized rats and the
corresponding speciﬁc bindings. TACs were acquired at least
6 days after the surgical implantation of the probes to exclude
postimplantation inﬂammatory reactions. TACs were derived
from the average of pixels from speciﬁc areas (4 pixels in the
cortex, 6 in the striatum, and 10 in the cerebellum). The
recorded TACs present a good consistency with previous
[11C]raclopride recordings with PET scanners.4,11 Moreover,
two major differences appear between anesthetized and
awake recordings: (1) the tracer concentration level at tracer
equilibrium is much higher in anesthetized animals, and (2)
the speciﬁc binding in the striatum is much higher in the
anesthetized animals, whereas it is similar in the cortex for
both cases.
A calculation of the B/F ratio in the striatum gives values
significantly higher in anesthetized than in awake rats (3.23 ±
0.5 and 1.79 ± 0.2, respectively). In contrast, values are
similar in the cortex: 0.3 ± 0.1 and 0.4 ± 0.2 in anesthetized
and awake rats, respectively. Both results provide evidence of
the fact that animal anaesthesia and/or motion interfere with
the tracer availability, uptake, and binding. Finally, compe-
titive binding experiments were performed to ascertain the
specificity of the [11C]raclopride uptake in the striatum for
both cases. As expected, tracer binding rapidly decreases in
competition conditions (Figure 4).
Discussion
In this study, striatal, cortical, and cerebellar TACs were
obtained in anesthetized and freely moving rats with PIXSIC
after intrajugular injections of [11C]raclopride. The proce-
dure allowed for wireless recording of the radioactivity
kinetics along the probes implanted in freely moving rats.
Clear correlations were obtained between the pixel locations
and the distribution of the radioligand. More precisely, the
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Figure 3. Cortical, striatal, and cerebellar time-activity curves after
intravenous bolus administration of [11C]raclopride in awake freely
moving (n = 3) (A) and anesthetized (n = 3) rats (B). Corresponding
speciﬁc binding in the striatum and cortex of awake and anesthetized
rats (C). Speciﬁc binding was obtained by subtracting the cerebellum
radioactivity (as a region without D2 receptors) from the radioactivity
found in the cortex or striatum. ID = injected dose.
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Figure 4. Alteration of specific binding of [11C]raclopride in the
striatum and the cortex after intravenous injection of 2 mg/kg raclopride
(arrow) in awake freely moving rats (n = 3). ID = injected dose.
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radioactivity counts were very low for all the pixels of the
probe placed within the cerebellum and for pixels of the
second probe partially located in the cortex. In contrast,
considering each pixel, there was a slight increase in the
radioactivity counts through the dorsoventral axis of the
striatal probe, conﬁrming D2 concentration heterogeneity
and its progressive density increase.12
In agreement with other results,3,4,13 and despite the dif-
ferent methodologies (clinical PET, microPET, RatCAP sys-
tem), speciﬁc binding of [11C]raclopride is much higher in
anesthetized than in freely moving rats. As suggested pre-
viously, potential causes of this effect are the enhancement of
peripheral metabolism in the awake case, changes in peripheral
metabolism and blood ﬂow, and interference of the anesthetic
with the dopaminergic transmission system (neurotransmitter
concentration modiﬁcations). This may include changes in the
rate of dopamine release, which can compete with [11C]
raclopride and modify its binding to D2 receptors, auto-
receptor effects, or the inﬂuence on tracer recapture through
blood-brain barrier transporters.4,13,14 These results further
highlight the potential bias induced by anesthetics on quanti-
tative measurements and conﬁrm the interest in developing
preclinical approaches in awake animals to facilitate compar-
ison with PET human data.
The TACs recorded with probes chronically implanted in
the brain did not show significant changes compared to
TACs recorded in acute experiments. Although some tissue
structures are slightly damaged due to probe implantation,
these results demonstrate that invasiveness does not affect the
pharmacokinetics recordings.
Due to the small weight and dimensions of PIXSIC com-
ponents (head socket and backpack), they do not interfere with
the movements of the rodent. Another advantage of the system
is that it is not sensitive to ambient light.15 Yet some limitations
remain due to the fragility of the probes and their connections
with the backpack that need to be solved for the next PIXSIC
generation. Another crucial limitation to be reduced is linked
to the relatively low sensitivity of the probe. We determined
that PIXSIC's single-pixel sensitivity is in the range of 30% of
the sensitivity of the beta-microprobe and a last-generation
microPET camera.6 This leads to higher doses of radiotracer to
be injected for a PIXSIC acquisition than for a classic micro-
PET acquisition (74 MBq in our conditions versus 18 MBq)
and to an averaging of data every minute. Since speciﬁc
activities of the brain PET radiotracers are classically obtained
between 37 and 74 GBq/mmol and cannot systematically be
guaranteed at higher values, particular attention will have to be
given to the injected amounts of radiotracer to stay within the
range of tracer doses. Further studies in instrumentation would
be desirable to improve the sensitivity of the current probes.
Conclusion
PIXSIC is a reliable approach for studying the dynamic
neurobiological processes underlying behavior in rodents.
PIXSIC provides accurate pharmacologic data in awake and
freely moving animals, which can be used to assess receptor
occupancy, availability of transporters and enzymes, and
glucose metabolism in particular brain regions. This tech-
nological approach constitutes a breakthrough toward
recordings of radiolabeled molecules kinetics in freely mov-
ing rodents and their comparison with the anesthetized
model. The next step will consist of determining the most
appropriate kinetic model with arterial input function mea-
surements. Another challenge will be the correlation of
molecular data with behavioral measurements through spe-
cific and relevant paradigms chosen to stress the potential of
such a combination.
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